Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma

Autor: Raje, Noopur, Kumar, Shaji, Hideshima, Teru, Ishitsuka, Kenji, Chauhan, Dharminder, Mitsiades, Constantine, Podar, Klaus, Le Gouill, Steven, Richardson, Paul, Munshi, Nikhil C., Stirling, David I., Antin, Joseph H., Anderson, Kenneth C.
Zdroj: In Blood 15 December 2004 104(13):4188-4193
Databáze: ScienceDirect